Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
eugenio.barone@uniroma1.it
Eugenio Barone
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"
E-mail:
eugenio.barone@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Editorial: Brain insulin resistance in neurodevelopmental and neurodegenerative disorders: mind the gap!
FRONTIERS IN NEUROSCIENCE
2021
Valorization of tomato waste as a source of carotenoids
MOLECULES
2021
Building the future therapies for down syndrome: the third international conference of the T21 research society
MOLECULAR SYNDROMOLOGY
2021
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
NEUROBIOLOGY OF DISEASE
2020
Heme oxygenase-1 in central nervous system malignancies
JOURNAL OF CLINICAL MEDICINE
2020
Down syndrome Is a metabolic disease: altered Insulin signaling mediates peripheral and brain dysfunctions
FRONTIERS IN NEUROSCIENCE
2020
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2020
The BACH1/Nrf2 axis in brain in down syndrome and transition to alzheimer disease-like neuropathology and dementia
ANTIOXIDANTS
2020
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention
PROGRESS IN NEUROBIOLOGY
2020
Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and nafld in human obesity
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2020
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome
NEUROTHERAPEUTICS
2020
Proteomics study of peripheral blood mononuclear cells in down syndrome children
ANTIOXIDANTS
2020
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration
ANTIOXIDANTS
2020
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease
MOLECULAR NEUROBIOLOGY
2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
NEUROBIOLOGY OF DISEASE
2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2019
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
REDOX BIOLOGY
2019
Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2019
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models
JOURNAL OF ALZHEIMER'S DISEASE
2018
Disturbance of redox homeostasis in down syndrome: role of iron dysmetabolism
FREE RADICAL BIOLOGY & MEDICINE
2018
« prima
< precedente
1
2
3
seguente ›
ultima »
Progetti di Ricerca
ABERRANT INSULIN SIGNALING CONTRIBUTES TO DEVELOPMENT OF ALZHEIMER DISEASE: SEARCH FOR NOVEL THERAPEUTIC STRATEGIES
Biliverdin reductase-A impairment mediates the development of insulin resistance in obesity and T2DM: a novel mechanism of action.
Unravelling a novel mechanism favoring brain insulin resistance development and its impact on Alzheimer disease neuropathology
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma